CVS Health CorporationCVSNYSE
Loading
Operating cash flow minus capital expenditures
3Y CAGR
-16.6%/yr
vs +18.5%/yr prior
5Y CAGR
-10.3%/yr
Recent deceleration
Acceleration
-35.1pp
Decelerating
Percentile
P57
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
1 yr
Consecutive growthStable
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $7.81B | +23.4% |
| 2024 | $6.33B | -39.1% |
| 2023 | $10.39B | -22.7% |
| 2022 | $13.45B | -14.6% |
| 2021 | $15.74B | +17.3% |
| 2020 | $13.43B | +29.2% |
| 2019 | $10.39B | +52.2% |
| 2018 | $6.83B | +12.1% |
| 2017 | $6.09B | -23.1% |
| 2016 | $7.92B | - |